ABOUT BIOXCYTE
Transforming Immune
Diagnostics at the Bedside
We are delivering rapid, point-of-need immune cell tests to empower time-critical clinical interventions and optimized patient care.
.png){kind=small}
Microfluidics
Precision chip technology that measures immune changes from a drop of whole blood.
At BioXcyte, we are transforming the landscape of healthcare diagnostics through cutting-edge point-of-care solutions. Our mission is to empower clinicians and patients with rapid, accurate, and accessible diagnostic tools that bridge the gap between early detection and timely intervention.
AI Diagnostics
Advanced AI models generate immune signatures at point-of-care.
Clinical Immunology
Led by scientists, engineers, and clinicians with deep expertise in clinical immunology and point-of-care diagnostics.
THE PROBLEM
A Critical Gap in
Immune Diagnostics
Our immune cells respond and guard against various health threats such as infection, cancer, and chronic diseases. Yet, there is a lack of rapid bedside tests for immune cell response to guide clinical diagnosis and therapy.
.png){kind=small}
Lack of Real-Time Immune Visibility
Clinicians treat immune‑driven conditions daily but rarely have a real‑time view of the underlying immune response, forcing many critical decisions to follow a “treat first, ask later” approach instead of relying on objective immune metrics.
Delayed Diagnosis
Current immune response laboratory tests often take hours to days, by which time critical conditions like infection and sepsis may have already progressed and the window for early treatment may be missed.
Overuse of Antibiotics
Without rapid immune response data, clinicians often default to broad-spectrum antibiotics, contributing to antimicrobial resistance and avoidable costs.
OUR SOLUTION
Immune Insights in
10 Minutes
BioXCyte delivers real-time immune visibility from a single drop of blood. Our proprietary system generates an immune signature that identifies infection, severity, and immune dysregulation — captured by AI models to provide critical information for urgent frontline decisions.
Rapid AI-Powered Diagnostics
Measures Immune Activity
Single Drop of Blood
Deployable Anywhere
POTENTIAL IMPACTS
Transforming Patient Outcomes
Across the Healthcare System
By enabling rapid, accurate immune diagnostics at the point of care, BioXcyte creates measurable value for patients, clinicians, and healthcare systems alike.
Informed Antibiotics Use
Faster Triage
Lighten Emergency
& ICU Load
OUR TEAM
LEAN TEAM WITH EXPERIENCE
IN THE FIELD
Kerwin Kwek Ph.D.
CEO, CTO
(Co-Founder)
Mui Teng Chua MD
Adjunct Associate Professor
(Clinical Co-Founder)
Win Sen Kuan MD
Adjunct Associate Professor
(Clinical Co-Founder)
Jongyoon Han Ph.D.
MIT Professor
(Scientific Advisor)
Contact Us
Let's Shape the
Future of Diagnostics
Whether you're a clinician, hospital administrator, researcher, or investor — we'd love to connect and explore how BioXcyte can transform immune diagnostics in your context.